Senior Analyst, Tunnell Contracting Officer Supporting the Office of the HHS/ASPR/BARDA, Washington, DC Background. We sought to expand the understanding of relationships of influenza outbreaks to ischemic heart disease (IHD)-related events.
We sought to further describe the relationship of intense influenza outbreak periods (intense-IOP) to IHD-related medical events over a 7-year period in Maryland residents ≥50 years of age. There were 4 primary study objectives. First, rates of IHD-related hospitalizations and deaths were temporally compared between intense-IOP and non-IOP. Second, the impact of increasing age on the rate ratios for IHD-related medical events during the intense-IOP over the non-IOP was examined. Third, the association between increased rates of IHD disease in each year and the intensity of that years' influenza season was examined. Finally, the association between increased rates of IHD disease in each year and the distribution of influenza subtypes and types that circulated during that influenza season was also examined.
MATERIALS AND METHODS

Defining the Study Intervals of Interest and Characterization of Influenza Viruses
Anonymous influenza testing results from several hospital laboratories and pediatric practices in Maryland were pooled and used to define influenza outbreak time periods for the 2001-2002 through the 2007-2008 influenza seasons as described elsewhere [5] . Briefly, the influenza season consisted of the fewest number of consecutive weeks that contained ≥85% of the positive influenza tests. The intense-IOP was defined as the consecutive 4-week period, including the peak week, with the most positive influenza culture or antigen tests. The non-IOP was defined as all weeks in each study year that were not within 2 weeks on either "side" of the influenza season for each year. Each study year was defined as July 1 of one year to the June 30 of the following year to ensure that it contained only one influenza season.
The estimated proportion of influenza types or subtypes that circulated in the Maryland area for each season was derived from the yearly National Respiratory and Enteric Virus Surveillance System (NREVSS) reports on HHS region 3, which includes Maryland, Delaware, Pennsylvania, West Virginia, Virginia, and the District of Columbia [6] .
Study Population and Medical Outcome Data
The study population consisted of all State of Maryland residents aged ≥50 years at the time of the recorded medical event of interest. The State of Maryland, Department of Health and Mental Hygiene, Health Services Cost Review Commission (HSCRC) provided data regarding all ED visits and hospitalizations from all 57 hospitals in Maryland from 1 July 2001 to 30 June 2008. Anonymous daily data extracted included the diagnostic International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) discharge codes for each ED visit or hospitalization, age in years, and county of residence. Hospitalizations that were a result of a transfer from another hospital were excluded. All ED encounters and hospitalizations were attributed to the county of residence regardless of the hospital visited. Maryland Department of Health and Mental Hygiene Vital Statistics Administration provided anonymous county-specific data for all deaths attributed to acute IHD. Maryland also classifies all deaths of citizens on the basis of their county of residence.
The primary discharge ICD-9 diagnostic codes inclusive of 410x, 411x, 413x were used to identify hospitalizations that were related to acute IHD for individuals ≥50 years of age. Anonymous death data included the day of the year the resident died, age of the resident in years, and county of residence. To maintain confidentiality of Maryland residents, the death data was extracted by age groups (ages 50-64 years and ≥65 years). To identify deaths related to IHD, primary ICD-10 codes I20 through and inclusive of I24 were used.
Data on medically attended acute respiratory illnesses (MAARIs) were used to estimate the intensity of influenza outbreaks. MAARI-related ED or hospitalization ICD-9 discharge diagnostic codes for Maryland residents ≥50 years of age were used to identify these events as modified from a previously published study [7] . These MAARI-related diagnoses included one or more primary or subsequent ICD-9 discharge codes for upper respiratory tract infections (460.x to 465.x), which included acute otitis media, sinusitis, mastoiditis, acute respiratory infection, common cold, pharyngitis, and tonsillitis. Codes for viral infection included 0.79.1-079. 4 Additionally, data were collected on individual hospitalizations whereby codes for both IHD and MAARI were identified. For this combined situation, the ICD-9 code for IHD had to be the primary discharge code and had to be associated with any subsequent ICD-9 codes for MAARI. As a noninfluenza-related medical outcome control, trauma-related hospital admissions for individuals ≥50 years of age were identified using ICD-9 codes inclusive of 800.x to 904.x, and 910.x to 959.x to see if these varied temporally with influenza outbreaks. Data were obtained regarding the estimated utilization of influenza vaccine prior to each influenza season by persons ≥50 years of age using the Maryland Behavior Risk Factor Surveillance System (BRFSS) [8] . Finally, to help put the data in the context of actual lives affected in Maryland, we obtained Maryland population data on individuals ≥50 years of age as of 1 July 2005 [9] .
Statistical Methods
Analyses were based on the counts of IHD-related hospitalizations, IHD-related deaths, MAARI-related ED visits, combined IHD-and MAARI-related hospitalizations, and trauma-related hospitalizations for Maryland residents ≥50 years of age on each day of each study year. Subgroup analyses were also performed for residents 50-64 years and those ≥65 years of age. These counts were analyzed using a Poisson regression model, allowing for overdispersion. The model included terms to allow the daily expectation to vary by year and by month of the year. The model also included terms to allow for higher rates during the intense-IOP than the non-IOP of each study year, and these resulted in the primary rate ratios (RRs) of interest. These RRs were used as a quantitative indicator of the excess rates of these medical outcomes during the intense-IOP compared to the non-IOP for each of the 7 study seasons.
For the entire 7 study years, relationship between age and the RR of IHD-related hospitalizations was assessed using linear regression. We did not calculate an age trend for IHD-related deaths because the data were provided in grouped age brackets of 50-64 years and ≥65 years of age to maintain confidentiality. Additionally, correlation coefficients (CCs) were calculated between each year's RR for MAARI-related ED visits, as a proxy for influenza seasonal intensity, to the same year's RR of IHD-related hospitalizations, IHD-related deaths or the combined IHD and MAARI-related hospitalizations.
Correlation coefficients were also calculated comparing the proportion of each of the 3 individual influenza types or subtypes circulating during each influenza season to the corresponding years' RR of IHD-related hospitalizations, IHD-related deaths, MAARI-related ED visits, or combined IHD and MAARI-related hospitalizations.
To assess the number of deaths or hospitalizations that were attributable to the impact of the intense-IOP, we calculated the expected number of events that would have occurred had the RR due to intense-IOP been equal to 1.0. This calculation was based on the model's estimates of annual and monthly expected values. Then we subtracted that number from the observed number of events.
Human Subject Protection
All data regarding influenza surveillance, hospitalization, deaths, and ED visits were examined and analyzed without personal identifiers. This study was reviewed and approved by the University of Maryland, Baltimore Institutional Review Board. Table 1 demonstrates the yearly Maryland specific intense-IOP and non-IOP intervals and the US Health and Human Services region 3 distribution of circulating influenza types and subtypes for each of the 7 study years. This table also includes the data on the utilization of influenza vaccine by 2 age groups, those 50-64 years of age and those ≥65 years of age. Table 2 demonstrates the number of IHD-related events during the 7 study years during the intense-IOP and the non-IOP. The mean number of events per day was greater during the intense-IOP than during the non-IOP, but some of this difference was due to seasonal affects. Table 3 demonstrates the RRs of medical outcomes of interest during the intense-IOP compared to the non-IOP by Maryland residents ≥50 years of age adjusting for seasonal effects (month) and year. These RRs are also exhibited for subsets of residents 50-64 years of age and those ≥65 years of age. Also demonstrated in Table 3 are the total numbers of medical events for combined 7 years for each age group. Of note, Table 3 demonstrates the total number of events for the Abbreviations: CI, confidence interval; IHD, acute ischemic heart disease; MAARI, medically attended acute respiratory illness. a Please note these data represent the sum of all medical events for the entire 12 months for the combined 7 study years, not just the period of time covered by the intense-IOP and non-IOP.
RESULTS
entire 12 months of each study year, whereas Table 2 represents the total number of medical events for the study periods of interest, which are the intense-IOP and the non-IOP. As a frame of reference, the estimated number of Maryland residents 50-64 years of age near the midpoint of our study period ( July 2005) was 987,401 and for residents aged ≥65 years was 644,560 [9] . For all 7 study years combined, residents ≥50 years of age had significantly increased RR of IHD-related: hospitalizations (RR = 1.06; P = .008); deaths (RR = 1.16; P = .002) and combined IHD and MAARI-related hospitalizations (RR = 1.42, P < .0001) during intense-IOPs relative to background periods (non-IOP). In contrast, no significant increases in RRs during the intense-IOP were observed when we considered hospitalizations for trauma for all 7 study years combined (RR = 1.02; 95% CI: .96-1.08, P = .55). Using the estimates from the combined analysis, we estimated that there were 360 IHD-related hospitalizations and 97 IHD-related deaths during the 7-year period attributable to the intense-IOP for individuals ≥50 years of age.
Within the total study population it appeared that the association between influenza outbreaks and IHD-related hospitalization varied by age. As seen in Table 3 , the excess rate of IHD-related outcomes during the intense-IOP was significant for those ≥65 years of age but not for individuals 50-64 years of age. This relationship between age and RRs for IHD-related events is further demonstrated by Figure 1 , which demonstrates that there was a gradual and significant rise in RRs for IHD-related hospitalizations with increasing age (P = .007 for age group trend).
Also, there was a clear age-associated difference in the occurrence of combination IHD-and MAARI-related hospitalizations. Only 7% of the 50-64 year olds with IHD-related admissions had a secondary MAARI-related diagnosis compared to 14% for the residents ≥65 years of age (P < .0001, χ 2 analysis). For all 7 seasons combined, the RR for MAARIrelated ED visits during the intense-IOP compared to the non-IOP by residents was similar in residents 50-64 years of age (RR = 1.68) and in residents ≥65 years of age (RR = 1.67).
As seen in Table 4 , the proportion of circulating A/H3N2 viruses in each year was significantly positively correlated with the factor (RR) by which IHD-related hospital admissions and combined IHD/MAARI-related hospitalizations increased during influenza outbreaks. Again the association was most prominent for the ≥65 year-old residents. Also, Table 4 demonstrates that the proportion of A/H3N2 viruses that circulated each season was significantly positively correlated to that season's RR of MAARI-related ED visits in residents >50 years of age. This relationship was not significant when comparing A/H3N2 proportions to the RR of IHD-related deaths at any age. The proportion of A/H1N1 and B viruses were actually generally associated with a decreased rise in RRs for clinical outcomes (data not shown).
Finally, Table 4 demonstrates that for individuals aged ≥65 years of age there was a positive correlation between influenza season intensity each year (as measured by the increase in RRs for MAARI-related ED visits) and the degree by which the RR of IHD-related hospitalizations increased during the influenza season of that year (CC = 0.77, P = .04). Additionally, there was a significant positive correlation between the RR for MAARI-related ED visits when compared to the RR for hospitalizations with the combined diagnoses of IHD and MAARI for residents ≥50 years of age (CC = 0.82, P = .02), and again this was most pronounced for the residents ≥65 years of age.
DISCUSSION
Our results demonstrate significant increases in the occurrence of IHD-related hospitalizations and deaths in Maryland residents ≥50 years of age during influenza outbreaks. These finding are not surprising given multiple reports relating the temporal association of IHD-related events to influenza outbreaks [4] . In the present study, the RR of IHD-related events during influenza outbreaks increase gradually and significantly with age and were most prominent in the age group of ≥65 years.
There are 3 unique findings of this study. First, the data from Table 4 and Figure 1 reveal a direct and significantly positive correlation of increasing age with increasing RR of IHD-related hospitalizations and deaths. The biologic explanation for this correlation likely involves both changes in the immune function with age as well as age-related increases in the susceptibility to coronary events. In addition, the effectiveness of influenza vaccine in the oldest age group may be suboptimal.
Second, there was a remarkable positive correlation of seasonal proportions of circulating A/H3N2 viruses compared to RRs of both MAARI-related ED visits and IHD-related hospitalizations during intense-IOP compared to non-IOP. These latter data conform to previous reports that, among all influenza viruses, A/H3N2 viruses are associated with the highest rates of influenza and pneumonia associated hospitalizations and deaths in the United States [2, 3] . The fact that we did not see a significant positive correlation of A/H3N2 viruses with IHD-related deaths is puzzling and may be related to the sample size.
Third, the magnitude of the increase in IHD-related events in the residents ≥65 years were positively correlated with the magnitude of the influenza season as measured by the increase in MAARI-related ED visits. These unique findings, combined with the temporal association of influenza outbreaks to IHDrelated events, suggest a direct causal relationship of influenza infections and acute IHD medical events in the oldest population.
The present study has several limitations. The retrospective design precludes uniform data entry of IHD, MAARI, or trauma-related diagnostic codes by the 57 hospitals in Maryland. However, it is reassuring that previous studies have found that primary ICD-9-CM codes have a high predictive value for acute myocardial infarction cases [10, 11] . The use of hospitalization data for trauma helped assure associations observed in this study were not artifacts of a general increased reporting of medical events at specific time periods. Another limitation is whether the medical events captured in our database may have been modified by factors such as influenza vaccine failure, undervaccination, or variations in vaccine match to circulating strains. BRFSS data indicate that the use of influenza vaccine each season was fairly uniform in Maryland; therefore, large variations in vaccination rates were not likely a factor in our results.
It is recognized that double counting and transfer bias could influence the estimation of IHD-related hospitalizations [12] . Excluding hospitalizations for patients transferred from another hospital reduced the impact of this latter limitation. Additionally, individuals may have had >1 ED visit or hospitalization per observation period. Paradoxically, individuals who live in border areas in Maryland may have opted to go to hospitals in the surrounding states, thus underestimating the number of MAARI or IHD-related medical events in these counties. Also, there may be unspecified demographic and environmental differences for Maryland residents compared to other US populations, which may not make our results generalizable. Another study limitation involved the use of regional NREVSS influenza type and subtype virus surveillance information. This data source represents 5 states and the District of Columbia, albeit inclusive of or in close proximity to Maryland. This source may or may not precisely reflect the circulating influenza viruses specifically in Maryland.
Finally, it has been recognized that adult hospitalizations for pneumonia and influenza lags behind children who are more likely tested for influenza virus or antigen [13, 14] . However, our Maryland surveillance system collected anonymous data; thus, the ages are not known. This likely makes our data on RR increases during intense-IOP somewhat conservative.
CONCLUSIONS
In conclusion, our data suggest a direct positive relationship of seasonal influenza outbreaks, as well as influenza season intensity to increased rates for serious acute IHD-related illnesses in Abbreviations: ED, emergency department; IHD, acute ischemic heart disease events; MAARI, medically attended acute respiratory illness; RR, rate ratios. a RR compares the rates of medical events during the intense influenza outbreak to the non-influenza outbreak periods.
older Maryland residents. There was a definite increase in rate for these IHD-related hospitalizations with increasing age. In addition, A/H3N2 viruses were clearly associated with more frequent MAARI-and IHD-related illnesses over the 7-year study period. Healthcare efforts need to be directed to encourage an increase in the proportion of older citizens who are vaccinated against influenza each year. In addition, the development of influenza vaccines with a more potent immune response in the elderly, the population most at risk for IHD-related illnesses during influenza outbreaks, would seem desirable.
